Skip to content
10-Q

Quarterly Report

Solid Biosciences Inc. SLDB

0001193125-26-219337

← back to feed
Filed
May 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 8, 2026 98.45M sh
Shares Diluted Q1 2026 · Mar 31, 2026 109.81M sh
Shares Diluted Q1 2026 · Mar 31, 2025 66.34M sh
Capex Q1 2026 · Mar 31, 2026 $165K
Capex Q1 2026 · Mar 31, 2025 $126K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$47.23M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$31.85M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $297.1M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $59.9M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $210.63M
Stockholders Equity Q1 2026 · Mar 31, 2026 $374.13M
Stockholders Equity Q1 2026 · Dec 31, 2025 $180.01M
Stockholders Equity Q1 2026 · Mar 31, 2025 $294.46M
Stockholders Equity Q1 2026 · Dec 31, 2024 $137.25M
Current Liabilities Q1 2026 · Mar 31, 2026 $30.28M
Current Liabilities Q1 2026 · Dec 31, 2025 $33.47M
Total Liabilities Q1 2026 · Mar 31, 2026 $48.76M
Total Liabilities Q1 2026 · Dec 31, 2025 $52.53M
Current Assets Q1 2026 · Mar 31, 2026 $396.79M
Current Assets Q1 2026 · Dec 31, 2025 $205.46M
Total Assets Q1 2026 · Mar 31, 2026 $422.89M
Total Assets Q1 2026 · Dec 31, 2025 $232.54M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.52
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.59
Eps Basic Q1 2026 · Mar 31, 2026 −$0.52
Eps Basic Q1 2026 · Mar 31, 2025 −$0.59
Sga Expense Q1 2026 · Mar 31, 2026 $11.17M
Sga Expense Q1 2026 · Mar 31, 2025 $9.14M
Rd Expense Q1 2026 · Mar 31, 2026 $46.14M
Rd Expense Q1 2026 · Mar 31, 2025 $30.91M
Operating Income Q1 2026 · Mar 31, 2026 −$57.31M
Operating Income Q1 2026 · Mar 31, 2025 −$40.05M